mAbs Therapy for Long-term Care Facilities
You work hard to keep the residents of your Long-term Care Facility safe. Monoclonal antibody treatments can help by reducing COVID related illnesses in nursing homes. Reduce the spread of COVID-19 in your facility with monoclonal antibody treatment.
mAb Therapy Safety & Effectiveness
mAbs is a safe and effective treatment to prevent severe illness and hospitalization due to COVID-19 in nursing homes and long-term care facilities. mAbs also reduces viral load and symptom severity and length. Monoclonal antibody treatment is safely administered via injection or IV by American Infusion trained nursing staff.
mAbs are administered directly after exposure to COVID-19 with a positive test up to 7 days after onset of symptoms. The treatment has proven a:
reduction in hospitalization and patient fatalities after receiving mAbs treatment
reduction of COVID infections among long-term care facilities
Which of Your Long-term Care Residents Could Benefit from mAbs?
Residents in a long-term care facility are more susceptible to severe illness from COVID-19 and dangerous spread of infection.
Due to residents’ vulnerability, all patients of long-term care facilities are potentially eligible for monoclonal antibody treatment upon confirmation of a positive COVID-19 test. Reach out to learn more about mAbs treatment qualification.
Reach out to learn more about mAbs qualification.
How does American Infusion’s monoclonal antibodies therapy service work?
Get in touch with us to request monoclonal antibodies in your nursing home or long-term care facility.
We’ll coordinate with you to determine the number of residents and staff that will receive monoclonal antibody treatment. We will send all forms ahead of time to make the process as seamless as possible.
American Infusion’s trained mAbs team comes fully equipped and ready to begin mAbs treatment at your facility.
There is no cost to the facility. We bill the residents insurance.
We Make the mAbs Process Easy for You
Easy, Convenient, Quick Treatment
Our staff handles the entire mAbs treatment procedure. The efficient, smooth process keeps your LTC or nursing home facility resources and employees available as usual.
Repeat Service Available
mAbs is effective as a COVID treatment for 30 days. If there are new or existing COVID-19 cases beyond that time period, we can provide an additional half-dose of mAbs for all residents with a positive test to extend their protection.
“Working with American Infusion to provide Monoclonal Antibodies to our residents was an extremely positive and pleasant experience. From coordination to the actual infusions, American Infusions has been accommodating and easy to work with. Their fantastic nursing team helped successfully administer to our most difficult patients. I highly recommend anyone who is in need of an infusion to work with American Infusion.” – D.P. Nursing Home Executive Director
Inquire about mAbs for your facility.